The glutathione S -transferase Gstt1 drives survival and dissemination in metastases

Christina M. Ferrer,Hyo Min Cho,Ruben Boon,Tiziano Bernasocchi,Lai Ping Wong,Murat Cetinbas,Elizabeth R. Haggerty,Irene Mitsiades,Gregory R. Wojtkiewicz,Daniel E. McLoughlin,Reem Aboushousha,Hend Abdelhamid,Sita Kugel,Esther Rheinbay,Ruslan Sadreyev,Dejan Juric,Yvonne M. W. Janssen-Heininger,Raul Mostoslavsky
DOI: https://doi.org/10.1038/s41556-024-01426-7
IF: 21.3
2024-06-12
Nature Cell Biology
Abstract:Identifying the adaptive mechanisms of metastatic cancer cells remains an elusive question in the treatment of metastatic disease, particularly in pancreatic cancer (pancreatic adenocarcinoma, PDA). A loss-of-function shRNA targeted screen in metastatic-derived cells identified Gstt1 , a member of the glutathione S -transferase superfamily, as uniquely required for dissemination and metastasis, but dispensable for primary tumour growth. Gstt1 is expressed in latent disseminated tumour cells (DTCs), is retained within a subpopulation of slow-cycling cells within existing metastases, and its inhibition leads to complete regression of macrometastatic tumours. This distinct Gstt1 high population is highly metastatic and retains slow-cycling phenotypes, epithelial–mesenchymal transition features and DTC characteristics compared to the Gstt1 low population. Mechanistic studies indicate that in this subset of cancer cells, Gstt1 maintains metastases by binding and glutathione-modifying intracellular fibronectin, in turn promoting its secretion and deposition into the metastatic microenvironment. We identified Gstt1 as a mediator of metastasis, highlighting the importance of heterogeneity and its influence on the metastatic tumour microenvironment.
cell biology
What problem does this paper attempt to address?